ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 742.00
-7.50 (-1.00%)
At close: Dec 5, 2025
ChemoMetec Revenue
In the fiscal year ending June 30, 2025, ChemoMetec had annual revenue of 495.57M DKK with 21.50% growth. ChemoMetec had revenue of 244.10M in the half year ending June 30, 2025, with 21.00% growth.
Revenue
495.57M
Revenue Growth
+21.50%
P/S Ratio
26.06
Revenue / Employee
2.92M
Employees
170
Market Cap
12.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 495.57M | 87.70M | 21.50% |
| Jun 30, 2024 | 407.87M | -36.53M | -8.22% |
| Jun 30, 2023 | 444.40M | 16.01M | 3.74% |
| Jun 30, 2022 | 428.39M | 147.26M | 52.38% |
| Jun 30, 2021 | 281.13M | 67.03M | 31.31% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 315.60B |
| Coloplast | 27.87B |
| Genmab | 24.48B |
| H. Lundbeck | 24.08B |
| Demant | 22.59B |
| GN Store Nord | 17.12B |
| Zealand Pharma | 9.16B |
| Bavarian Nordic | 6.89B |
ChemoMetec News
- 4 weeks ago - Full Year 2025 Chemometec A/S Earnings Call Transcript - GuruFocus
- 10 months ago - Half Year 2025 Chemometec A/S Earnings Call Transcript - GuruFocus